This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Cisco Technology, Inc., Genfleet Therapeutics (Shanghai) Inc., Zhejiang Genfleet Therapeutics Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 21,378 
1 out of 7 
1 out of 2 Years Active: 2026
Title: Innovations by Inventor Kai Ma
Introduction
Kai Ma is an inventor based in Shanghai, China. He is known for his contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific gene mutations and diseases. Although he currently holds no granted patents, his work is significant in the realm of drug development.
Latest Patent Applications
Kai Ma has submitted several notable patent applications. One of his latest applications is for a pyrimidine-fused cyclic compound, which has an inhibitory effect on KRAS gene mutation. This compound, represented by formula (A), includes a pharmaceutically acceptable salt, a stereoisomer, or a solvate thereof. It is intended for use in the preparation of anticancer drugs. Another application involves a fused ring-substituted six-membered heterocyclic compound, represented by formula (IA) or formula (IC). This compound also includes a pharmaceutically acceptable salt, a stereoisomer, a solvate, or a prodrug thereof. The application details its use in the preparation of drugs aimed at preventing and/or treating diseases related to HPK1 activity.
Conclusion
Kai Ma's innovative work in pharmaceutical compounds showcases his commitment to advancing medical science. His latest patent applications reflect a focus on developing effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile